The Genomic Medicine at VA Study (NCT04331535) | Clinical Trial Compass
UnknownNot Applicable
The Genomic Medicine at VA Study
United States1,076 participantsStarted 2020-07-17
Plain-language summary
This trial will determine the clinical effectiveness of polygenic risk score testing among patients at high genetic risk for at least one of six diseases (coronary artery disease, atrial fibrillation, type 2 diabetes mellitus, colorectal cancer, breast cancer, or prostate cancer), measured by time-to-diagnosis of prevalent or incident disease over 24 months.
Who can participate
Age range50 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 50-70 years at enrollment
* No known diagnosis of the following conditions, initially screened by the International Classification of Disease (ICD) codes or other electronic health record (EHR) data using validated methods and then confirmed with potential patient-participants during recruitment: coronary artery disease, atrial fibrillation, type 2 diabetes, colorectal cancer, breast cancer, prostate cancer
Exclusion Criteria:
* Patients will be ineligible if they:
* Have a known diagnosis of at least one of the six diseases of interest
* Are younger than age 50 or older than age 70
* Are pregnant
* Are incarcerated or institutionalized